Regeneus' osteoarthritis treatment, HiQCell® shows strong results

Regeneus' osteoarthritis treatment, HiQCell® shows strong results Regeneus (ASX: RGS) should trade firmer after revealing further results from the joint registry used to track the safety and effectiveness of its innovative cell therapy, HiQCell®, in the treatment of osteoarthritis. The… Continue Reading